Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ubben

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Malaria Journal|September 7, 2010
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjectsSalim Abdulla, Baraka Amuri, Abdunoor M Kabanywanyi, et al.
Malaria Journal|August 2, 2011
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysisSteven E Kern, Alfred B Tiono, Michael Makanga, et al.
The American Journal of Tropical Medicine and Hygiene|December 2, 2010
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern LaosMayfong Mayxay, Sommay Keomany, Maniphone Khanthavong, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
Plos One|November 26, 2009
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trialQuique Bassat, Modest Mulenga, Halidou Tinto, et al.
Malaria Journal|July 24, 2012
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in IndiaNicola Gargano, David Ubben, Silva Tommasini, et al.
Malaria Journal|December 20, 2011
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight rangesQuique Bassat, Raquel González, Sónia Machevo, et al.
Malaria Journal|December 4, 2012
Malaria in infants aged less than six months - is it an area of unmet medical need?Umberto D'Alessandro, David Ubben, Kamal Hamed, et al.
Lancet (London, England)|October 18, 2008
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialSalim Abdulla, Issaka Sagara, Steffen Borrmann, et al.
Emerging Infectious Diseases|June 17, 2015
Malaria Prevalence among Young Infants in Different Transmission Settings, AfricaSerign J Ceesay, Lamine Koivogui, Alain Nahum, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Malaria Journal|September 7, 2010
Early clinical development of artemether-lumefantrine dispersible tablet: palatability of three flavours and bioavailability in healthy subjectsSalim Abdulla, Baraka Amuri, Abdunoor M Kabanywanyi, et al.
Malaria Journal|August 2, 2011
Community screening and treatment of asymptomatic carriers of Plasmodium falciparum with artemether-lumefantrine to reduce malaria disease burden: a modelling and simulation analysisSteven E Kern, Alfred B Tiono, Michael Makanga, et al.
The American Journal of Tropical Medicine and Hygiene|December 2, 2010
A phase III, randomized, non-inferiority trial to assess the efficacy and safety of dihydroartemisinin-piperaquine in comparison with artesunate-mefloquine in patients with uncomplicated Plasmodium falciparum malaria in southern LaosMayfong Mayxay, Sommay Keomany, Maniphone Khanthavong, et al.
Nature Communications|November 27, 2014
Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysisLucy C Okell, Matthew Cairns, Jamie T Griffin, et al.
Plos One|November 26, 2009
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trialQuique Bassat, Modest Mulenga, Halidou Tinto, et al.
Malaria Journal|July 24, 2012
Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in IndiaNicola Gargano, David Ubben, Silva Tommasini, et al.
Malaria Journal|December 20, 2011
Similar efficacy and safety of artemether-lumefantrine (Coartem®) in African infants and children with uncomplicated falciparum malaria across different body weight rangesQuique Bassat, Raquel González, Sónia Machevo, et al.
Malaria Journal|December 4, 2012
Malaria in infants aged less than six months - is it an area of unmet medical need?Umberto D'Alessandro, David Ubben, Kamal Hamed, et al.
Lancet (London, England)|October 18, 2008
Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multicentre trialSalim Abdulla, Issaka Sagara, Steffen Borrmann, et al.
Emerging Infectious Diseases|June 17, 2015
Malaria Prevalence among Young Infants in Different Transmission Settings, AfricaSerign J Ceesay, Lamine Koivogui, Alain Nahum, et al.
Pageof 3